Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopsy
Report summarizes biopsy study findings from Harvard University
February 10th, 2009
According to recent research from the United States, "The objective of our study was to determine the predictive value of percutaneous imaging-guided biopsy of peritoneal and omental masses. A retrospective study of 111 patients who underwent biopsy of a peritoneal or omental mass from 1998 to 2006 was performed." "Biopsy results were classified as diagnostic ( malignant or benign) or nondiagnostic. Sensitivity, specificity, and negative predictive value ( NPV) were calculated for all patients, and the Fisher-Freeman-Halton exact test was used to determine whether test characteristics varied by patient history ( presence of a known cancer), mass size (< 4 cm vs >=...
Source: Cancer Weekly (2009-02-10)
|
